The case for complement component 5 as a target in neurodegenerative disease

.

Source: Expert Opinion on Therapeutic Targets - February 17, 2023 Category: Drugs & Pharmacology Authors: Amelia Stennett Kallie Friston Claire L. Harris Adam J. M. Wollman Agnieszka K. Bronowska Katrina S. Madden Source Type: research